OXY

Thinking about trading options or stock in Apple, Eli Lilly, General Mills, Activision Blizzard, or Occidental Petroleum?

Retrieved on: 
Friday, September 23, 2022

NEW YORK, Sept. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, LLY, GIS, ATVI, and OXY.

Key Points: 
  • NEW YORK, Sept. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, LLY, GIS, ATVI, and OXY.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies

Retrieved on: 
Wednesday, September 7, 2022

RA'ANANA, Israel, Sept. 7, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announces the completion of an animal study that was conducted at Lahav C.R.O (contract research organization) by leading intensive care unit, or ICU, and respiratory specialists, who are members of Inspira's Scientific Advisory Board. The completion of the animal study is an additional important step toward initiating human studies using the HYLA™ blood sensor.

Key Points: 
  • The completion of the animal study is an additional important step toward initiating human studies using the HYLAblood sensor.
  • During an animal study, the HYLA blood sensor performed measurements of blood parameterswith results being compared to numerous blood samples taken and analyzed using a routine blood gas analyzer, which is considered the standard of care used by hospitals today.
  • The animal study was performed following prior successful ex-vivo data obtained with the HYLAblood sensor in the Company's laboratory.
  • The lab results, accompanied by the encouraging animal study data, are important steps toward human studies.

Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference

Retrieved on: 
Thursday, September 1, 2022

RA'ANANA, ISRAEL, Sept. 1, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

Key Points: 
  • RA'ANANA, ISRAEL, Sept. 1, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N.
  • Ltd. (NASDAQ: IINN) (NASDAQ: IINNW)(the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, today announced that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the H.C. Wainwright 24th Annual Global Investor Conference on Monday, September 12, 2022.
  • For more information regarding these events, please visit Inspira Technologies' Investor Relations page here .
  • Copyright 2018-2022 Inspira Technologies OXY B.H.N.

Thinking about trading options or stock in Zoom Video, Occidental Petroleum, MicroStrategy, Twitter, or JD.Com?

Retrieved on: 
Tuesday, August 23, 2022

NEW YORK, Aug. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZM, OXY, MSTR, TWTR, and JD.

Key Points: 
  • NEW YORK, Aug. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZM, OXY, MSTR, TWTR, and JD.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

Inspira™ Technologies Reports Second Quarter 2022 Financial Results

Retrieved on: 
Thursday, August 11, 2022

RA'ANANA, Israel, Aug. 11, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the second quarter ended June 30, 2022.

Key Points: 
  • Ltd. (Nasdaq: IINN) (Nasdaq:IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the second quarter ended June 30, 2022.
  • April 6, 2022 - Inspira Technologies announced a deployment agreement for the InspiraTM ART system in the Israeli market to potentially target $15 million.
  • July 7, 2022 - Inspira Technologies announced a strategic agreement in the U.S. with a potential value of $59 million for the deployment of 3,889 HYLA Blood Sensors.
  • Financial highlights for the quarter endedJune 30, 2022
    Research and development expenses for the three months endedJune 30, 2022,were $2.7 million, an increase of $1.2 million compared to the first quarter of 2022.

Inspira™ Technologies Reveals Next Generation Liby™ System, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market

Retrieved on: 
Monday, July 11, 2022

The Liby System is intended to target the $531million global ECMO market.

Key Points: 
  • The Liby System is intended to target the $531million global ECMO market.
  • The Inspira Technologies Liby system currently under development, is expected to be submitted to the U.S. Food and Drug Administration (FDA) for approval, during the first half of 2023.
  • The Inspira Technologies Liby system is designed to be a new generation ECMO system, with potential advantages that may improve usability and patient care.
  • Dagi Ben-Noon, Inspira Technologies' Chief Executive Officer, stated:
    "The Liby system is intended to target one of three market segments within Inspira Technologies product scope.

Inspira™ Technologies Reveals Next Generation Liby™ ECMO, an Extracorporeal Membrane Oxygenation System, Targeting a $531 Million Global ECMO Market

Retrieved on: 
Monday, July 11, 2022

The Liby System is intended to target the $531million global ECMO market.

Key Points: 
  • The Liby System is intended to target the $531million global ECMO market.
  • The Inspira Technologies Liby system currently under development, is expected to be submitted to the U.S. Food and Drug Administration (FDA) for approval, during the first half of 2023.
  • The Inspira Technologies Liby system is designed to be a new generation ECMO system, with potential advantages that may improve usability and patient care.
  • Dagi Ben-Noon, Inspira Technologies' Chief Executive Officer, stated:
    "The Liby system is intended to target one of three market segments within Inspira Technologies product scope.

Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients - Potentially Targets $2.5 Billion ABG Market

Retrieved on: 
Wednesday, July 6, 2022

RA'ANANA, Israel, July 6, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, revealed the development of the HYLA™ blood sensor. Without the need to take actual blood samples from patients, Inspira's non-invasive optical blood sensor is being designed to perform real-time and continuous blood monitoring to alert physicians of immediate signs of changes in a patient's clinical condition. The HYLA blood sensor is targeting the potential $2.5 billion Point of Care testing, ABG (Arterial Blood Gas) analyzer market.

Key Points: 
  • Ltd. (NASDAQ: IINN) (NASDAQ:IINNW)(the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, revealed the development of the HYLA blood sensor.
  • The HYLA blood sensor is targeting the potential $2.5 billion Point of Care testing, ABG (Arterial Blood Gas) analyzer market.
  • The HYLA blood sensor is being designed as a new platform based on key technologies being developed for Inspira's ART system, designed to reduce the need for invasive mechanical ventilation.
  • The HYLA non-invasive blood sensor is attached to the outer walls of a tube that has blood flowing through it.

Thinking about trading options or stock in Nike, Cigna Corp, Occidental Petroleum, Apple, or NVIDIA?

Retrieved on: 
Tuesday, June 28, 2022

NEW YORK, June 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKE, CI, OXY, AAPL, and NVDA.

Key Points: 
  • NEW YORK, June 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NKE, CI, OXY, AAPL, and NVDA.
  • Click a link below then choose between in-depth options trade idea report or a stock score report.
  • Options Report Ideal trade ideas on up to seven different options trading strategies.
  • The report shows all vital aspects of each option trade idea for each stock.

NextMart, Inc. - Planned Acquisition of New Mexico Water Rights

Retrieved on: 
Thursday, June 9, 2022

The acquisition of more New Mexico water rights is in direct response tothe current fast-growing needs of its current clients, and new clients that are coming on board, due to the increased oil and gas activity in the Permian Basin.

Key Points: 
  • The acquisition of more New Mexico water rights is in direct response tothe current fast-growing needs of its current clients, and new clients that are coming on board, due to the increased oil and gas activity in the Permian Basin.
  • Water stations provide a vital source of water needed to drill oil and gas wells.
  • This new revenue stream can be expanded as we endeavor to develop additional water stations in our market."
  • View original content (Emco Oilfield Services, LLC Acquisition - Dated: January 21, 2022 -Credit to PRNewswire): https://www.prnewswire.com/news-releases/nextmart-inc--acquisition-of-oi...